[Treatment of spastic vascular diseases].
D000470:Alkaloids; D001532:Atropa belladonna / Q000627:therapeutic use*; D001463:Barbiturates / Q000627:therapeutic use*; D006801:Humans; D009128:Muscle Spasticity; D009573:Nitrites / Q000627:therapeutic use*; D010208:Papaverine / Q000627:therapeutic use*; D010276:Parasympatholytics; D016491:Peripheral Vascular Diseases / Q000628:therapy*; D013806:Theophylline / Q000627:therapeutic use*; D014652:Vascular Diseases; D015016:Yohimbine
D000470:Alkaloids; D001463:Barbiturates; D009573:Nitrites; D010276:Parasympatholytics; D015016:Yohimbine; D013806:Theophylline; D010208:Papaverine
BARBITURATES/therapeutic use; BELLADONNA/therapeutic use; NITRITES/therapeutic use; PAPAVERINE/therapeutic use; THEOPHYLLINE/therapeutic use; VASCULAR DISEASES, PERIPHERAL/therapy; YOHIMBINE
Zur Behandlung spastischer Gefässerkrankungen.